NCT05737771View on ClinicalTrials.gov

To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 25, 2023

Primary Completion Date

March 31, 2023

Study Completion Date

June 30, 2023

Conditions
FDCDiabetes Mellitus, Type 2
Interventions
DRUG

DWC202213

DWC202213

DRUG

DWJ1563

DWJ1563

DRUG

DWP16001

DWP16001

Trial Locations (1)

28644

RECRUITING

Chungbuk National University Hospital, Cheongju-si

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT05737771 - To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination | Biotech Hunter | Biotech Hunter